Hydrogen-rich saline reduces oxidative stress and inflammation by inhibit of JNK and NF-κB activation in a rat model of amyloid-beta-induced Alzheimer's disease

Afaq, 2003, Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea constituent (−)-epigallocatechin-3-gallate, Oncogene, 22, 1035, 10.1038/sj.onc.1206206 Akiyama, 2000, Inflammation and Alzheimer's disease, Neurobiol. Aging, 21, 383, 10.1016/S0197-4580(00)00124-X Arlt, 2002, Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease, Curr. Opin. Lipidol., 13, 289, 10.1097/00041433-200206000-00009 Cai, 2009, Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model, Brain Res., 1256, 129, 10.1016/j.brainres.2008.11.048 Gabbita, 1998, Increased nuclear DNA oxidation in the brain in Alzheimer's disease, J. Neurochem., 71, 2034, 10.1046/j.1471-4159.1998.71052034.x Hensley, 1995, Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation, J. Neurochem., 65, 2146, 10.1046/j.1471-4159.1995.65052146.x Kim, 2010, Pathological roles of MAPK signaling pathways in human diseases, Biochim. Biophys. Acta, 1802, 396, 10.1016/j.bbadis.2009.12.009 Lane, 2005, Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease, J. Lipid Res., 46, 949, 10.1194/jlr.M400486-JLR200 Levites, 2002, Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures, Biochem. Pharmacol., 63, 21, 10.1016/S0006-2952(01)00813-9 Li, 2010, Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress, Brain Res., 1328, 152, 10.1016/j.brainres.2010.02.046 Lin, 2006, Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases, Nature, 443, 787, 10.1038/nature05292 Nakashima-Kamimura, 2009, Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice, Cancer Chemother. Pharmacol., 64, 753, 10.1007/s00280-008-0924-2 Ohsawa, 2007, Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals, Nat. Med., 13, 688, 10.1038/nm1577 Ohsawa, 2008, Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice, Biochem. Biophys. Res. Commun., 37, 1195, 10.1016/j.bbrc.2008.10.156 Poldiori, 2004, Oxidative stress and risk factors for Alzheimer's disease: clues to prevention and therapy, J. Alzheimer's Dis., 6, 185, 10.3233/JAD-2004-6211 Pratico, 2008, Oxidative stress hypothesis in Alzheimer's disease: a reappraisal, Trends Pharmacol. Sci., 29, 609, 10.1016/j.tips.2008.09.001 Pratico, 2000, Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease, Am. J. Med., 109, 577, 10.1016/S0002-9343(00)00547-7 Simonian, 1996, Oxidative stress in neurodegeneratative disease, Annu. Rev. Pharmocol. Toxicol., 36, 83, 10.1146/annurev.pa.36.040196.000503 Tabner, 2005, Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia, J. Biol. Chem., 280, 35789, 10.1074/jbc.C500238200 Wang, 2005, Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease, J. Neurochem., 93, 953, 10.1111/j.1471-4159.2005.03053.x Yan, 1996, RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease, Nature, 382, 685, 10.1038/382685a0 Zhu, 2002, The role of mitogen-activated protein kinase pathways in Alzheimer's disease, Neurosignals, 11, 270, 10.1159/000067426